Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Verrienti

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Endocrinology|March 15, 2017
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cellsValentina Maggisano, Marilena Celano, Giovanni Enrico Lombardo, et al.
Clinical Endocrinology|September 6, 2012
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytomaAngela V D'Elia, Franco Grimaldi, Stefano Pizzolitto, et al.
Endocrine|June 17, 2011
Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian familySandra Mastroianno, Massimo Torlontano, Alfredo Scillitani, et al.
Clinical Endocrinology|December 31, 2009
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterizationMaria D Castellone, Antonella Verrienti, Deva Magendra Rao, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2007
Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patientsMassimo Torlontano, Cosimo Durante, Isabella Torrente, et al.
Endocrine|June 8, 2020
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissueAntonella Verrienti, Valeria Pecce, Luana Abballe, et al.
Endocrine|January 21, 2019
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cellsValentina Maggisano, Marilena Celano, Saverio Massimo Lepore, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 7, 2015
A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2Antonella Verrienti, Antonella Carbone, Pasquale Bellitti, et al.
Medicine|February 9, 2017
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case reportElisa Giannetta, Andrea M Isidori, Cosimo Durante, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Endocrinology|March 15, 2017
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cellsValentina Maggisano, Marilena Celano, Giovanni Enrico Lombardo, et al.
Clinical Endocrinology|September 6, 2012
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytomaAngela V D'Elia, Franco Grimaldi, Stefano Pizzolitto, et al.
Endocrine|June 17, 2011
Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian familySandra Mastroianno, Massimo Torlontano, Alfredo Scillitani, et al.
Clinical Endocrinology|December 31, 2009
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterizationMaria D Castellone, Antonella Verrienti, Deva Magendra Rao, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2007
Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patientsMassimo Torlontano, Cosimo Durante, Isabella Torrente, et al.
Endocrine|June 8, 2020
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissueAntonella Verrienti, Valeria Pecce, Luana Abballe, et al.
Endocrine|January 21, 2019
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cellsValentina Maggisano, Marilena Celano, Saverio Massimo Lepore, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 7, 2015
A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2Antonella Verrienti, Antonella Carbone, Pasquale Bellitti, et al.
Medicine|February 9, 2017
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case reportElisa Giannetta, Andrea M Isidori, Cosimo Durante, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
Pageof 6